When was Anamay Biotech founded?

Anamay Biotech was founded in 2017.

Where is Anamay Biotech located?

Anamay Biotech is headquartered in Hyderabad, India. It is registered at Ground floor, Plot No. 2 Padmaja Co-op Housing Society, Kakaguda, Karkhana, Hyderabad, Hyderabad, Telangana, India, 500015.

Who is the current CEO of Anamay Biotech?

Jalachari Ella of Anamay Biotech. They have also founded 1 company.

How many employees does Anamay Biotech have?

As of Mar 31, 2024, Anamay Biotech has 83 employees, reflecting a 14% year-over-year growth in headcount.

Is Anamay Biotech a funded company?

Anamay Biotech is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Anamay Biotech?

Annual revenue of Anamay Biotech is ₹19.5Cr as on Mar 31, 2025.

Where does Anamay Biotech rank among its competitors?

Anamay Biotech ranks 779th amongst 2526 active competitors, of which 862 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Erasca, which secured $45M in Mar, 2024.

Who are the top competitors of Anamay Biotech?

Anamay Biotech's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Juno Therapeutics. Among them, Erasca secured the most recent funding round in March, 2024.

Anamay Biotech - 2026 Company Profile, Team, Competitors & Financials

Anamay Biotech is an unfunded company based in Hyderabad (India), founded in 2017 by Jalachari Ella. It operates as a Developer of dermatology-related products, including therapeutics, cosmeceuticals, and baby care. Anamay Biotech has not raised any funding yet. The company has 2526 active competitors, including 862 funded and 620 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Juno Therapeutics.

Company Details

Developer of dermatology-related products, including therapeutics, cosmeceuticals, and baby care. It offers Recombinant Growth Factors as products to address various skin-related concerns and offer innovative solutions for wound care and tissue repair.

Website: anamaybiotech.com
Social
Email ID: *****@anamaybiotech.com
Registered Address: Ground floor, Plot No. 2 Padmaja Co-op Housing Society, Kakaguda, Karkhana, Hyderabad, Hyderabad, Telangana, India, 500015

Key Metrics

Founded Year

2017

Location

Hyderabad, India

Stage

Unfunded

Ranked

779^th among 2526 active competitors

Annual Revenue

₹19.5Cr as on Mar 31, 2025

Employee Count

83 as on Mar 31, 2024

Similar Companies

LEO Pharma & 145 more

View Anamay Biotech's full profile

Anamay Biotech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ANAMAY BIOTECH PRIVATE LIMITED CIN: U73100TG2017PTC117308 , India, Active	May 24, 2017	$2.3M (As on Mar 31, 2025)	83 (As on Mar 31, 2024)

Anamay Biotech has not raised any funding rounds yet.

The founders of Anamay Biotech is Jalachari Ella. Jalachari Ella is the CEO of Anamay Biotech.

Here are the details of Anamay Biotech's key team members:

Jalachari Ella: Founder & CEO of Anamay Biotech.

View details of Anamay Biotech's Founder profiles and Board Members

Anamay Biotech's employee count trend

Anamay Biotech has 83 employees as of Mar 24. The total employee count is 14.0% more than what it was in Mar 23. Here is Anamay Biotech's employee count trend over the years:

Uncover Anamay Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Anamay Biotech include Jazz Pharmaceuticals, Sana Biotechnology and Juno Therapeutics. Here is the list of Top 10 competitors of Anamay Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of genetically engineered cell therapies for multiple disorders	$821M	Bezos Expeditions, F-Prime Capital & 17 others	75/100
3rd	Juno Therapeutics 2013, Seattle (United States), Acquired	Global biopharmaceutical company discovering, developing, and delivering innovative medicines	$317M	BB Biotech, RA Capital Management & 14 others	74/100
4th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	74/100
5th	Blueprint Medicines 2008, Cambridge (United States), Acquired	Developer of selective kinase inhibitors for patients with genomically defined cancers	$115M	Third Rock Ventures, Nextech Invest & 20 others	73/100
6th	Kronos Bio 2017, San Mateo (United States), Acquired	Developer of small molecule based therapeutics for cancer treatment	$271M	Omega Funds, Vida Ventures & 18 others	72/100
7th	MacroGenics 2000, Rockville (United States), Public	Developer of novel biologics for the treatment of autoimmune disorders, cancer and infectious disease	$126M	Nextech Venture, Ventures West & 29 others	72/100
8th	LEO Pharma 1908, Copenhagen (Denmark), Late Stage	Developer of drugs for treating dermatology diseases	$560M	Nordic Capital	71/100
9th	Harbour BioMed 2016, Shanghai (China), Public	Developer of antibody therapeutics in immunology and oncology disease	$313M	GIC, Hudson Bay Capital & 19 others	71/100
10th	Erasca 2018, San Diego (United States), Public	Developer of small molecule based therapeutics for cancer	$300M	Cormorant Asset Management, Arch Venture Partners ... & 13 others	70/100
779th	Anamay Biotech 2017, Hyderabad (India), Unfunded	Developer of dermatology-related products, including therapeutics, cosmeceuticals, and baby care	-	-	42/100